Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities

Planta Medica

Volumn 65, Issue 3, 1999, Pages 218-221

  Kim, So Ra ^a   Hwang, Se Young ^a   Jang, Young Pyo ^a   Park, Mi Jung ^a   Markelonis, George J ^b   Oh, Tae Hwan ^b   Kim, Young Choong ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Corydalis ternata; Dementia; Papaveraceae; Protopine; Reversible AChE inhibitor; Scopolamine induced memory impairment; Tacrine

Indexed keywords

CHOLINESTERASE; PROTOPINE; VELNACRINE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CHOLINESTERASE INHIBITION; CONCENTRATION RESPONSE; DEMENTIA; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; FRACTIONATION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PLANT;

ALKALOIDS; AMNESIA; ANIMALS; BENZOPHENANTHRIDINES; BERBERINE ALKALOIDS; CHOLINESTERASE INHIBITORS; DEMENTIA; MALE; MICE; MICE, INBRED ICR; NOOTROPIC AGENTS; PAPAVER; PLANTS, MEDICINAL;

ANIMALIA; CORYDALIS; CORYDALIS TERNATA; PAPAVERACEAE;

EID: 0032970917     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-13983     Document Type: Article

References (26)

1. 1 Smith, C. M. (1989) in: Neurotransmitters, Drugs and Disease, (Webster, R. A., Jordan, C. C., eds.), p. 428, Blackwell Scientific Publ. Co., London.
2. 2 Lang, W., Henke, H. (1983) Brain Res. 267, 271-280.
3. 3 Davies, P., Maloney, A. J. (1976) Lancet 21, 1403.
4. 4 Sparks, D. L., Dekosky, S. T., Markesbery, W. R. (1988) Arch. Neurol. 45, 994-999.
5. 5 Rossor, M. N. (1982) Neurotransmitters and CNS Disease, Lancet 27, 1200.
6. 6 Perry, E. K., Perry, R. H., Bllese, D. G., Tonlinsin, B. E. (1977) Lancet 22, 189.
7. 7 Antuono, P. G. (1995) Arch. Intern. Med. 155, 1766-1772.
8. 8 Ebmeier, K. P., Hunter, R., Curran, S. M., Dougal, N.J., Murray, C. L., Wyper, D. J., Patterson, J., Hanson, M. T., Siegfried, K., Goodwin, G. M. (1992) Psychopharmacol. 180, 103-109.
9. 9 Forsyth, D. R., Wilcock, G. K., Morgan, R. A., Tauman, C. A., Ford, J. M., Roberts, C. J. C. (1989) Clin. Pharmac. Ther. 46, 634-641.
10. 10 Schwartz, W. K., Kohlstaekt, E. V. (1986) Life Sci. 38, 1021-1028.
11. 11 Giacobini, E., Cuadra, G. (1994) in: ALzheimer's disease: Therapeutic Strategies, (Giacobini, E., Becker, R., eds.), pp. 155-171, Birkhauser, Boston.
12. 12 Tanaka, T., Metori, K., Mineo, S., Hirotani, M., Furuga, T., Kobayashi, S. (1993) Planta Med. 59, 200-202.
13. 13 Matsuda, H., Shiomoto, H., Manba, K., Kubo, M. (1988) Planta Med. 54, 498-501.
14. 14 Ko, F. N., Wu, T. S., Lu, S. T., Wu, Y. C., Huang, T. F., Teng, C. M. (1992) Jpn. J. Pharmacol. 58, 1-9.
15. 15 Kardos, J., Blasko, G., Simonyi, M. (1986) Arzneimittelforschung Drug Res. 36, 939-940.
16. 16 Ustunes, L., Laekeman, G. M., Gozler, B., Vlietinck, A. J., Ozer, A., Herman, A. G. (1988) J. Nat. Prod. 51, 1021-1022.
17. 17 Joshi, S. B., Haider, S. I., Pelletier, S. W. (1990) Planta Med. 56, 418-419.
18. 18 Ellman, G. L., Courtney, K. D., Andres, V., Featherstone, R. M. (1961) Biochem. Pharmacol. 7, 88-95.
19. 19 Christensen, H., Maltby, N., Jorm, A. F., Creasey, H., Broe, G. A. (1992) Brain 115, 1681-1699.
20. 20 Murphy, K. J., O'Connell, A. W., Regan, C. M. (1996) J. Neurochem. 67, 1268-1274.
21. 21 Bianchi, M., Ferrario, P., Clavenna, A., Panerai, A. E. (1997) Neuroreport 8, 1775-1778.
22. 22 Khromova, I., Voronina, T., Kraineva, V. A., Zolotov, N., Mannisto, P. T. (1997) Behav. Brain Res. 86, 49-57.
23. 23 Rhodes, M. E., Li, P. K., Burke, A. M., Johnson, D. A. (1997) Brain Res. 773, 28-32.
24. 24 Drago, F., Coppi, G., Antonuzzo, P. A., Valerio, C., Genazzani, A. A., Grassi, M., Raffaele, R., Scapagnini, U. (1996) Neurobiol Aging 17, 67-71.
25. 25 Smith, R. D., Grzelak, M. E., Coffin, V. L. (1997) Pharmacol. Biochem. Behav. 58, 657-664.
26. 26 Hiramatsu, M., Murasawa, H., Nabeshima, T., Kameyama, T. (1998) J. Pharmacol. Exp. Ther. 284, 858-867.